$56.50 -0.58 (-1.02%)
11/27/2009 1:00 PM

Amgen, Inc. (AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Featured Broker Partners